mizoribine has been researched along with Vasculitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Itabashi, M; Matsuno, S; Sugimoto, H; Takei, T; Yamanaka, N; Yumura, W | 1 |
| Arimura, Y; Kawashima, S; Yoshihara, K | 1 |
| Abe, H; Fujimatsu, S; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Muta, T; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M | 1 |
| Kawakami, T; Soma, Y | 1 |
| Hashimoto, Y; Hirayama, A; Hirayama, K; Kobayashi, M; Koyama, A; Nagase, S; Nagata, M; Shimizu, Y; Usui, J; Yamagata, K; Yoh, K | 1 |
| Harada, T; Horita, Y; Kohno, S; Miyazaki, M; Nishioka, Y; Suyama, N; Tadokoro, M; Taura, K | 1 |
| Hamaguchi, M; Ishino, H; Kawahito, Y; Kohno, M; Tsubouchi, Y; Wada, M; Yamamoto, A; Yoshikawa, T | 1 |
1 review(s) available for mizoribine and Vasculitis
| Article | Year |
|---|---|
[ANCA associated vasculitis and PRGN].
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Disease Progression; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Ribonucleosides; Vasculitis | 2009 |
1 trial(s) available for mizoribine and Vasculitis
| Article | Year |
|---|---|
Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Female; Glomerulonephritis; Humans; Male; Middle Aged; Pilot Projects; Purines; Renal Circulation; Ribonucleosides; Treatment Outcome; Vasculitis | 2004 |
5 other study(ies) available for mizoribine and Vasculitis
| Article | Year |
|---|---|
Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Biopsy; Comorbidity; Drug Therapy, Combination; Edema; Female; Glomerulonephritis, Membranoproliferative; Humans; IgA Vasculitis; Immunoglobulin A; Immunosuppressive Agents; Kidney; Leg; Nephrotic Syndrome; Remission Induction; Ribonucleosides; Vasculitis | 2021 |
A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone; Renal Dialysis; Renal Insufficiency; Ribonucleosides; Treatment Outcome; Vasculitis | 2009 |
Successful use of mizoribine in a patient with sarcoidosis and cutaneous vasculitis.
Topics: Adult; Biopsy; Female; Humans; Immunosuppressive Agents; Ribonucleosides; Sarcoidosis; Skin; Treatment Outcome; Vasculitis | 2011 |
Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Recurrence; Remission Induction; Ribonucleosides; Vasculitis | 2006 |
Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers.
Topics: Aged; Cryoglobulinemia; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Prednisolone; Purpura, Hyperglobulinemic; Ribonucleosides; Skin Ulcer; Treatment Outcome; Vasculitis | 2007 |